Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke
Abstract Background N-acetylcysteine (NAC) is a tolerable and safe drug capable of reducing free radicals and other oxidants. We included 74 individuals with ischemic stroke in this randomized, single-blind clinical trial and placed them into intervention (n = 37) and control (n = 37) groups. In the...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-05-01
|
| Series: | Beni-Suef University Journal of Basic and Applied Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43088-023-00380-x |
| _version_ | 1797831988382531584 |
|---|---|
| author | Mohammad Farzandway Daniel Elieh-Ali-Komi Ehsan Mohammadi Noori Farjam Goudarzi Rezan Ashayeri Ahmadabad Azadeh Eshraghi Zahra Mirzaasgari Seyed Mohammad Navabi Amir Kiani |
| author_facet | Mohammad Farzandway Daniel Elieh-Ali-Komi Ehsan Mohammadi Noori Farjam Goudarzi Rezan Ashayeri Ahmadabad Azadeh Eshraghi Zahra Mirzaasgari Seyed Mohammad Navabi Amir Kiani |
| author_sort | Mohammad Farzandway |
| collection | DOAJ |
| description | Abstract Background N-acetylcysteine (NAC) is a tolerable and safe drug capable of reducing free radicals and other oxidants. We included 74 individuals with ischemic stroke in this randomized, single-blind clinical trial and placed them into intervention (n = 37) and control (n = 37) groups. In the intervention group, in addition to standard treatment for ischemic stroke, they received NAC at a dose of 100 mg/kg bolus and then at a dose of 10 mg/kg/h for 10 h. The control group received only standard stroke treatment. Blood samples were taken before starting NAC and standard stroke treatment and 24 h after receiving the drug to measure the catalase, paraoxonase, malondialdehyde (MDA), neopterin, total antioxidant capacity (TAC), and total oxidant status (TOS) parameters. The National Institutes of Health Stroke Scale (NIHSS) was also calculated before and after 24 h, 2 weeks, 1 month, and 3 months after starting the drug. Results There was no significant difference between the results of parameters before and after standard treatment in control group; however, NAC could significantly reduce TOS (P = 0.02) in the intervention group. Moreover, NAC administration could notably decrease NIHSS calculated at each time point when compared to control group. After subgrouping the intervention group, NAC could increase catalase (P < 0.001), paraoxonase (P < 0.001), and TAC (P < 0.001) while decreased MDA (P < 0.001), neopterin (P = 0.001) and TOS (P < 0.001) significantly in intervention-responding subgroup and decreased NIHSS significantly at each monitored time point. Conclusion NAC can be promising as a complementary drug and a powerful antioxidant in reducing oxidative stress and improving cognitive function in individuals with stroke. |
| first_indexed | 2024-04-09T14:00:30Z |
| format | Article |
| id | doaj.art-e085cd98158840628a77e593e2496ae7 |
| institution | Directory Open Access Journal |
| issn | 2314-8543 |
| language | English |
| last_indexed | 2024-04-09T14:00:30Z |
| publishDate | 2023-05-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Beni-Suef University Journal of Basic and Applied Sciences |
| spelling | doaj.art-e085cd98158840628a77e593e2496ae72023-05-07T11:20:36ZengSpringerOpenBeni-Suef University Journal of Basic and Applied Sciences2314-85432023-05-0112111110.1186/s43088-023-00380-xInvestigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with strokeMohammad Farzandway0Daniel Elieh-Ali-Komi1Ehsan Mohammadi Noori2Farjam Goudarzi3Rezan Ashayeri Ahmadabad4Azadeh Eshraghi5Zahra Mirzaasgari6Seyed Mohammad Navabi7Amir Kiani8Student Research Committee, Kermanshah University of Medical SciencesInstitute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu BerlinPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical SciencesRegenerative Medicine Research Center (RMRC), Kermanshah University of Medical SciencesNeurology Department, Khatam Alanbia Hospital, Iranshahr University of Medical SciencesDepartment of Clinical Pharmacy, Iran University of Medical SciencesShefa Neuroscience Research Center, Khatam Alanbia HospitalStudent Research Committee, Kermanshah University of Medical SciencesPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical SciencesAbstract Background N-acetylcysteine (NAC) is a tolerable and safe drug capable of reducing free radicals and other oxidants. We included 74 individuals with ischemic stroke in this randomized, single-blind clinical trial and placed them into intervention (n = 37) and control (n = 37) groups. In the intervention group, in addition to standard treatment for ischemic stroke, they received NAC at a dose of 100 mg/kg bolus and then at a dose of 10 mg/kg/h for 10 h. The control group received only standard stroke treatment. Blood samples were taken before starting NAC and standard stroke treatment and 24 h after receiving the drug to measure the catalase, paraoxonase, malondialdehyde (MDA), neopterin, total antioxidant capacity (TAC), and total oxidant status (TOS) parameters. The National Institutes of Health Stroke Scale (NIHSS) was also calculated before and after 24 h, 2 weeks, 1 month, and 3 months after starting the drug. Results There was no significant difference between the results of parameters before and after standard treatment in control group; however, NAC could significantly reduce TOS (P = 0.02) in the intervention group. Moreover, NAC administration could notably decrease NIHSS calculated at each time point when compared to control group. After subgrouping the intervention group, NAC could increase catalase (P < 0.001), paraoxonase (P < 0.001), and TAC (P < 0.001) while decreased MDA (P < 0.001), neopterin (P = 0.001) and TOS (P < 0.001) significantly in intervention-responding subgroup and decreased NIHSS significantly at each monitored time point. Conclusion NAC can be promising as a complementary drug and a powerful antioxidant in reducing oxidative stress and improving cognitive function in individuals with stroke.https://doi.org/10.1186/s43088-023-00380-xStrokeOxidative stressN-acetylcysteineAntioxidant biomarkers |
| spellingShingle | Mohammad Farzandway Daniel Elieh-Ali-Komi Ehsan Mohammadi Noori Farjam Goudarzi Rezan Ashayeri Ahmadabad Azadeh Eshraghi Zahra Mirzaasgari Seyed Mohammad Navabi Amir Kiani Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke Beni-Suef University Journal of Basic and Applied Sciences Stroke Oxidative stress N-acetylcysteine Antioxidant biomarkers |
| title | Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| title_full | Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| title_fullStr | Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| title_full_unstemmed | Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| title_short | Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| title_sort | investigation of the effect of n acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke |
| topic | Stroke Oxidative stress N-acetylcysteine Antioxidant biomarkers |
| url | https://doi.org/10.1186/s43088-023-00380-x |
| work_keys_str_mv | AT mohammadfarzandway investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT danieleliehalikomi investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT ehsanmohammadinoori investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT farjamgoudarzi investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT rezanashayeriahmadabad investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT azadeheshraghi investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT zahramirzaasgari investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT seyedmohammadnavabi investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke AT amirkiani investigationoftheeffectofnacetylcysteineonserumlevelsofoxidativeinflammatorybiomarkersinpatientswithstroke |